CCL5 and androgen insensitivity syndrome: In AIS patients, RANTES was significantly associated with CAS (unadjusted OR: 1.17; 95% CI: 1.03–1.33; p = 0.017), and the adjusted odds ratio of RANTES was statistically significant (OR: 1.024; 95% CI: 1.008–1.041; p = 0.003; Table 3).